Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Background: Atopic dermatitis is observed in up to 20% of children, hence the importance of tools to support its evaluation.
Objective: To determine the validity and reliability of the Spanish adaptation of the IDQOL questionnaire in patients <4 years of age with atopic dermatitis (AD).
Methods: Translation and back-translation of the questionnaire; a pilot test was done in 30 children with AD to arrive at a final version. Internal reliability (Cronbach's alpha) and correlation of IDQOL and SCORAD scores (Pearson correlation coefficient) were measured.
Results: 102 children aged between two and 48 months were included. The Pearson correlation coefficient (r) of IDQOL and SCORAD scores was 0.697 (p = 0.0001), indicating a high positive correlation. The correlation between the severity measured by the caregiver and the SCORAD score (r = 0.565, p = 0.0001) proved to be low positive. The internal consistency of IDQOL using Cronbach's alpha was 0.84, indicating good consistency of the instrument for assessing quality of life.
Conclusion: The IDQOL questionnaire in Spanish is a valid measure of quality of life in patients < 4 years with AD and is useful in monitoring and in clinical trials.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.29262/ram.v63i3.159 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!